Acadia Pharmaceuticals reported $81.67M in Selling and Administration Expenses for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Acadia Pharmaceuticals ACAD:US $ 81.67M 15.12M
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Alexion Pharmaceuticals ALXN:US $ 342.9M 101.5M
Alnylam Pharmaceuticals ALNY:US $ 142.07M 11.75M
Aptinyx Inc APTX:US $ 4.93M 142K
Arena Pharmaceuticals ARNA:US $ 30.3M 1.63M
Biogen BIIB:US $ 654.1M 16.8M
Biomarin Pharmaceutical BMRN:US $ 183.33M 828K
Bristol Myers Squibb BMY:US $ 1.79B 95M
Cara Therapeutics CARA:US $ 5.88M 262K
Corcept Therapeutics CORT:US $ 30.53M 504K
Cytokinetics CYTK:US $ 26.2M 5M
Eisai 4523:JP 79.76B 5.03B
Eli Lilly And LLY:US $ 1.58B 107.8M
Gw Pharmaceuticals GWPH:US 101.05M 2.71M
Intercept Pharmaceuticals ICPT:US $ 53.34M 4.32M
Intra Cellular Therapies ITCI:US $ 70.5M 646.73K
Johnson & Johnson JNJ:US $ 6B 73M
Marinus Pharmaceuticals MRNS:US 9.45M 2.62M
Moderna Inc MRNA:US 168M 47M
Neurocrine Biosciences NBIX:US $ 154.6M 11.4M
Pfizer PFE:US $ 2.73B 61M
Prothena PRTA:US 11.96M 923K
Ptc Therapeutics PTCT:US $ 69.25M 374K
Sarepta Therapeutics SRPT:US $ 61.13M 11.22M
Seattle Genetics SGEN:US $ 180.28M 15.15M
Ultragenyx Pharmaceutical RARE:US $ 53.88M 473K
Vanda Pharmaceuticals VNDA:US $ 32.46M 4.11M
Vertex Pharmaceuticals VRTX:US $ 198.19M 3.52M
YTE INCY:US $ 190.7M 21.84M
Zogenix ZGNX:US $ 39.56M 5.68M